论文部分内容阅读
我院内科自1990年2月至1992年1月,应用蝮蛇抗栓酶治疗某些缺血性脑血管病21例,疗效满意,现报道如下. 一、一般资料本组男15例,女6例;年龄49～72岁,平均58.8岁.21例中短暂性脑缺血发作(T IA)10例,脑血栓形成10例,脑血栓形成后遗症1例,T IA合并高血压3例、心肌梗塞1例:脑血栓形成合并高血压6例、冠心病4例;脑血栓形成后遗症合并高血压1例、糖尿病1例.本组21例均符合1986年中华医学会第二次全国脑血管病学术会议第三次修订诊断标准.
In our hospital internal medicine from February 1990 to January 1992, the application of viper antithrombin enzyme in the treatment of some ischemic cerebrovascular disease in 21 cases, with satisfactory results, are reported as follows.A general information of this group of 15 males and females Six cases were aged from 49 to 72 years with an average of 58.8 years old.There were 10 cases of transient ischemic attack (T IA), 10 cases of cerebral thrombosis, 1 case of cerebral thrombosis, 3 cases of TIA complicated with hypertension, 1 case of myocardial infarction: cerebral thrombosis with hypertension in 6 cases, coronary heart disease in 4 cases; cerebral thrombosis sequelae with hypertension in 1 case, diabetes in 1. 21 cases of this group are in line with the 1986 Chinese Medical Association Second National Cerebrovascular Systematic revision of diagnostic criteria for the third time.